Predictive factors for the efficacy of brolucizumab in refractory polypoidal choroidal vasculopathy following aflibercept resistance. [PDF]
Yoshinaga A +6 more
europepmc +1 more source
Recognition and treatment of polypoidal choroidal vasculopathy and age-related macular degeneration in British Columbia. [PDF]
Lee Y +7 more
europepmc +1 more source
Juxtapillary choroidal excavation with polypoidal choroidal vasculopathy: An unusual association
Maitreyi Chowdhury, Pukhraj Rishi
doaj +1 more source
The <i>CFH-CFHR5</i> Locus in Wet Age-Related Macular Degeneration, Polypoidal Choroidal Vasculopathy, and Central Serous Chorioretinopathy. [PDF]
Chen ZJ +9 more
europepmc +1 more source
Combined Therapy Versus Fortified Anti-VEGF Monotherapy in Type C Polypoidal Choroidal Vasculopathy: Long-Term Outcomes and Exploratory Biomarker Insights. [PDF]
Chao WW, Chao HW, Chao HM.
europepmc +1 more source
Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal Vasculopathy. [PDF]
Fukuda Y +4 more
europepmc +1 more source
Localization of Polypoidal Choroidal Vasculopathy in Fluorescein Angiography Using Semisupervised Deep Learning With Labeled and Unlabeled Images. [PDF]
Lin CC +6 more
europepmc +1 more source
Choroidal Venous Architecture and Polypoidal Lesion Distribution in Subtypes of Polypoidal Choroidal Vasculopathy Using Widefield Imaging. [PDF]
Zhang Y +9 more
europepmc +1 more source
Full-Thickness Macular Hole Formation After Intravitreal Faricimab Injection for Polypoidal Choroidal Vasculopathy. [PDF]
Tavonvunchai F, Chanwimol K.
europepmc +1 more source

